The initial public offer of Mankind Pharma was subscribed 9% till 4.00 pm on day 1 of the offer. Click here to subscribe the IPO.
The retail investors’ part was subscribed 8%, non-institutional investors’ (NIIs’) portion was subscribed 20%. However, there were no bids for the QIB category.
The Rs 4,300-crore IPO is completely an offer for sale (OFS), will conclude on April 27. Investors can bid for 13 shares in 1 lot and in multiples thereof.
The company has reserved about 50% of the issue size for qualified institutional buyers (QIBs), 35% for retail investors and the remaining 15% for non-institutional investors.
Mankind Pharma IPO important details
| Open date | April 25 |
| Close date | April 27 |
| Lot size | 13 |
| IPO size (Rs crore) | Rs 4,326.36 Cr |
| IPO price range (Rs) | Rs 1026-1080 per share |
| Minimum investment | Rs 14,040 |
| Basis of allotment date | May 3 |
| Refunds date | May 4 |
| Credit to demat account date | May 5 |
| Listing date | May 8 |
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
